These findings are in accordance with earlier reports showing that IFN-γ rescues MHC class I expression on CSCs of different origins,31, 32 and offer hope for efficient targeting of CSCs by adoptively transferred tumour-infiltrating lymphocytes and engineered T cells. The gene discussed is IFNG; the disease is neoplasm.